Compile Data Set for Download or QSAR
Report error Found 690 Enz. Inhib. hit(s) with Target = 'GTPase KRas [G13D]'
TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678343(US20240174690, Example II-192)
Affinity DataIC50: 7nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678346(US20240174690, Example II-195)
Affinity DataIC50: 7nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678181(US20240174690, Example II-13)
Affinity DataIC50: 8nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678193(US20240174690, Example II-26)
Affinity DataIC50: 8nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678197(US20240174690, Example II-31)
Affinity DataIC50: 8nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678242(US20240174690, Example II-77)
Affinity DataIC50: 8nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678335(US20240174690, Example II-182)
Affinity DataIC50: 8nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678187(US20240174690, Example II-19)
Affinity DataIC50: 9nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678237(US20240174690, Example II-72)
Affinity DataIC50: 9nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678259(US20240174690, Example II-94)
Affinity DataIC50: 9nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678344(US20240174690, Example II-193 | US20240174690, Exa...)
Affinity DataIC50: 9nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678192(US20240174690, Example II-25)
Affinity DataIC50: 11nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678189(US20240174690, Example II-21)
Affinity DataIC50: 12nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678280(US20240174690, Example II-116)
Affinity DataIC50: 17nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678235(US20240174690, Example II-70)
Affinity DataIC50: 19nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678112(US20240174690, Example I-4)
Affinity DataIC50: 20nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678352(US20240174690, Example II-201)
Affinity DataIC50: 27nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678219(US20240174690, Example II-54)
Affinity DataIC50: 33nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678200(US20240174690, Example II-34)
Affinity DataIC50: 38nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678241(US20240174690, Example II-76)
Affinity DataIC50: 41nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678220(US20240174690, Example II-55)
Affinity DataIC50: 47nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678321(US20240174690, Example II-165 | US20240174690, Exa...)
Affinity DataIC50: 48nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591398(US11566007, Example A76 | US11566007, Example A112)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591582(US11566007, Example A260)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591584(US11566007, Example A262)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591585(US11566007, Example A263)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591586(US11566007, Example A264)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591587(US11566007, Example A265)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591589(US11566007, Example A267)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591590(US11566007, Example A268)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591592(US11566007, Example A270)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591616(US11566007, Example A294)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591618(US11566007, Example A296)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591620(US11566007, Example A298)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591622(US11566007, Example A300)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591640(US11566007, Example A319)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591654(US11566007, Example A333)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591659(US11566007, Example A338)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591709(US11566007, Example A388)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591784(US11566007, Example A464 | US11566007, Example A46...)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591784(US11566007, Example A464 | US11566007, Example A46...)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591847(US11566007, Example A527)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591856(US11566007, Example A536 | US11566007, Example A53...)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591862(US11566007, Example A542 | The synthesis of 1-(4-(...)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591984(US11566007, Example A664)
Affinity DataIC50: 55nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678327(US20240174690, Example II-171)
Affinity DataIC50: 64nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678183(US20240174690, Example II-15)
Affinity DataIC50: 71nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678157(US20240174690, Example I-39 | US20240174690, Examp...)
Affinity DataIC50: 146nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D]/Son of sevenless homolog 1 [564-1049](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM678215(US20240174690, Example II-49)
Affinity DataIC50: 173nMAssay Description:These assays measure the inhibitory effect of compounds on KRAS mutant protein-protein interactions using the Alpha Screen technology by Perkin Elmer...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGTPase KRas [G13D](Human)
Revolution Medicines

US Patent
LigandPNGBDBM591350(US11566007, Example A28 | Synthesis of (2S)-N-[(8S...)
Affinity DataIC50: 550nMAssay Description:A variety of Ras proteins may be inhibited by compounds of the present invention (e.g., K-Ras, N-Ras, H-Ras, and mutants thereof at positions 12, 13 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 690 total ) | Next | Last >>
Jump to: